NCT05952466

Brief Summary

We designed this study to examine whether COVID-19 infection could lead to retinal and choroidal microvascular involvement in school-age children (6-18 years) in a pandemic peak in China.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

July 18, 2023

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 19, 2023

Completed
Last Updated

July 19, 2023

Status Verified

July 1, 2023

Enrollment Period

2 months

First QC Date

July 18, 2023

Last Update Submit

July 18, 2023

Conditions

Keywords

COVID-19 infectionretinal microvascular involvementchoroidal thicknessschool-age children

Outcome Measures

Primary Outcomes (2)

  • Macular and peripapillary blood perfusion density

    The blood flow density represents the proportion of the blood flow signal area in the scanning area to the overall area, expressed in units of mm-1, which can show the blood vessel perfusion and circulation.

    5 minutes

  • Macular and peripapillary retinal thickness

    Macular fovea and peripheral retinal thickness, retinal thickness around the optic nerve

    3 minutes

Secondary Outcomes (2)

  • Fundus lesions

    2 minutes

  • Vascular distribution shape in macular area

    2 minutes

Study Arms (2)

COVID-19 infection group

School-age children infected recently with COVID-19

control group

School-age children without COVID-19

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Totally 100 school-age children (6-18 years) were enrolled in this study. All subjects had visited the ophthalmology clinic for routine ocular examinations.Eighty children with COVID-19 infection were included in the case group. Controls without COVID-19 infection were matched to COVID-19 infection cases by a ratio of 1:4 using frequency matching on age and gender. The following age subgroups were used for matching: 6-10, 10-14 and 15-18 years. A list of numbers computer-generated by a research member (Xu Zhang) was used to match the controls. The collected data included demographic and clinical data, as well as retinal and choroidal microvascular parameters.

You may qualify if:

  • Totally 100 school-age children (6-18 years) were enrolled in this study. All subjects had visited the ophthalmology clinic for routine ocular examinations. Refraction after ciliary muscle paralysis, myopia ≥ -6.0 spherical diopter, astigmatism ≤ 2.5 cylindrical diopter.

You may not qualify if:

  • The child or guardian did not agree to participate in the study.
  • Children could cooperate to complete the ocular examination.
  • The child had previous diseases affecting visual function and fundus, except for the diagnosis of refractive error.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Guangzhou First People's Hospital

Guangzhou, Guangdong, China

Location

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Yuehong Zhang

    Guangzhou First People's Hospital, Guangzhou, Guangdong China

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

July 18, 2023

First Posted

July 19, 2023

Study Start

February 1, 2023

Primary Completion

March 31, 2023

Study Completion

March 31, 2023

Last Updated

July 19, 2023

Record last verified: 2023-07

Locations